| (HKD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 2.03M | 58.07% |
| Operating expense | — | — |
| Net income | -359.88M | 19.59% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 1672.HK returned -35.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -15.7% |
| 1 year | -35.3% |
| 5 years | +240.8% |
| All-time high | $16.64 (Mar 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in 1672.HK would be worth today ›No. Ascletis Pharma Inc. has not paid a dividend in the past 12 months.
Ascletis Pharma Inc. is part of the Healthcare sector.
Ascletis Pharma Inc. has a market cap of 10.11B HKD, based on the latest quote.
